- $4.58bn
- $4.24bn
- $43.07m
Annual income statement for IONQ, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 2.1 | 11.1 | 22 | 43.1 |
Cost of Revenue | |||||
Gross Profit | — | 1.06 | 8.24 | 14.1 | 22.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.66 | 40.8 | 96.9 | 180 | 276 |
Operating Profit | -0.66 | -38.7 | -85.7 | -158 | -232 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.2 | -106 | -48.5 | -158 | -332 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.2 | -106 | -48.5 | -158 | -332 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.2 | -106 | -48.5 | -158 | -332 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.2 | -106 | -48.5 | -158 | -332 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.436 | -0.772 | -0.245 | -0.779 | -1.56 |
Dividends per Share |